透過您的圖書館登入
IP:3.138.102.114
  • 期刊
  • OpenAccess

Comparative Efficacy of Piroxicam, Indomethacin and Placebo-Controlled in the Treatment of Degenerative Osteoarthritis

Piroxicam, indomethacin及安慰劑對治療退化性關節炎的藥效比較

摘要


多數的非類固醇抗炎藥是有效的抗炎上痛劑。在本項為時6週,98位病人的研究中,由醫師與病人共同評估多項piroxicam與indometh對膝或股退化性關節炎的療效。結果顯示,兩種非類固醇抗炎藥對治療退化性關節炎具有相同的藥效,研究並發現piroxicam與indomethacin對關節功能的改善,在統計學上顯然有意義於優於安慰劑,在腸胃道方面,病人對piroxicam的耐受性,在統計上較indomethacin為佳。

並列摘要


In this six-week study, multiple categories were designed to discern the clinical efficacy of piroxicam (15mg orally once daily) and indomethacin (25mg orally four times a day) in treatment of 98 patients with osteoarthritis (O.A.) of the knee and/or hip. Based on evaluations by both physicians and patients, there were no statistically significant difference between the two NSAIDs-treated groups in most of the efficacy parameter studied (all p>0.001). This study also indicated that both prioxicam and indomethacin were superior to placebo in the treatment of O.A. (all p<0.001). In accord with the gastrointestinal tract, the piroicam-treated subjects had significant lower incidence of digestive problem compared with the indomethacin group (p<0.001).

延伸閱讀